PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Hepatoprotective activity observed at a dose of 25 mg/kg in experimental models [PMID:39861572]
Moderate anti-inflammatory activity observed at a dose of 100 mg/kg in experimental models [PMID:39861572]
Significant local hemostatic activity, reducing bleeding time [PMID:39861572]
Reduction of Reactive Oxygen Species levels in specific cancer cell lines in vitro [PMID:32708873]
Evidence summary
PubMed sources
- 1.PMID: 39861572 (2025) — Ajuga reptans L. Herb Extracts: Phytochemical Composition and Pharmacological Activity Screening. · Plants (Basel, Switzerland)
- 2.PMID: 38873640 (2024) — The Complete Genome Sequence of Ajuga reptans (Lamiaceae, Lamiales), Bugleweed. · Biodiversity genomes
- 3.PMID: 19338317 (2009) — C-29 ecdysteroids from Ajuga reptans var. reptans. · Journal of natural products
- 4.PMID: 21804257 (2011) — Four new iridoid glucosides from Ajuga reptans. · Chemical & pharmaceutical bulletin
- 5.PMID: 32708873 (2020) — Study on Ajuga reptans Extract: A Natural Antioxidant in Microencapsulated Powder Form as an Active Ingredient for Nutraceutical or Pharmaceutical Purposes.